维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="Sorror ML"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies显示文摘	Nemecek ER Guthrie KA Sorror ML		0，，03：	1
	2	Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission:combined FHCRC and MDACC experiences显示文摘	Sorror ML Giralt S Sandmaier BM	2007	Blood2007，110，13：	1
	3	Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies显示文摘	Nemecek ER Guthrie KA Sorror ML	2011	Biol Blood Marrow Transplant2011，17，3：	1
	4	Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission:combined FHCRC and MDACC experiences显示文摘	Sorror ML Giralt S Sandmaier BM	2007	Blood2007，110，：	1
	5	Cornorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation 显示文摘	Sorror ML Sandmaier BM Storer BE	2007	J Clin Oncol2007，25，：	1
	6	Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with al- Iogeneic hematopoietic cell transplantation after nonmyeloablative conditioning显示文摘	Sorror ML Storer BE Sandmaier BM	2008	J Clin Oncol2008，26，30：	1
	7	Pre-transplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality 显示文摘	Sorror ML Martin P J Storb RF	2014	Blood2014，124，2：	1
	8	The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation显示文摘	WANG Z SORROR ML LEISENRING W	2010	Br J Haema- tol2010，149，：	1
	9	Hematopoietic cell transplantation(HCT)-specific comorbidity index:a new tool for risk assessment before allogeneic HCT显示文摘	Sorror ML Maris MB Storb R	2005	Blood2005，106，8：	1
	10	Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia显示文摘	Sorror ML Maris MB Sandmaier BM	2005	J Clin Oncol2005，23，16：	1
	11	Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia:relapse-free survival is determined by karyotype and comorbidities显示文摘	Eissa H Gooley TA Sorror ML	2011	Biol Blood Marrow Transplant2011，17，6：	1
	12	Hematopoietic cell trans- plantation (HCT)- specific comorbidity index:a new tool for risk assessment before allogeneic HCT显示文摘	Sorror ML Maris MB Storb R	2005	Blood2005，106，8：	1
	13	The dynamic international prognostic scoring system for myelofibro- sis predicts outcomes after hematopoietic cell trans- plantation显示文摘	Scott BL Gooley TA Sorror ML	2012	Blood2012，119，：	1
	14	The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation显示文摘	Wang Z Sorror ML Leisenring W	2010	Br J Haematol2010，149，1：	1
	15	Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation显示文摘	Sorror ML Sandmaier BM Storer BE	2007	J Clin Oncol2007，25，27：	1
	16	Hematopoietic cell transplantation (HCT)-Specific comorbidity index:a new tool for risk assessment before allogeneic HCT显示文摘	Sorror ML Maris MB Storb R	2005	Blood2005，106，8：	1
	17	Hematopoietic cell transplantation(HCT)-speeific eomorbidity index: a new tool for riks assessment before allogeneic HCT显示文摘	Sorror ML Maris MB Storb R	2005	Blood2005，106，8：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费